As of Mar 27
| +2.04 / +1.27%|
The 20 analysts offering 12-month price forecasts for Amgen have a median target of 178.50, with a high estimate of 208.00 and a low estimate of 139.00. The median estimate represents a +9.79% increase from the last price of 162.59.
The current consensus among 26 polled investment analysts is to Buy stock in Amgen. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.